Carboplatin Intensification Beneficial for Group 3 Medulloblastoma
Therapy intensification with carboplatin improved five-year event-free survival in children with high-risk group 3 medulloblastoma only
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.